Clinical Trial

Detection of Electrodermal Activity in Pain 2

Study acronym: DEEP 2
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to investigate the association between self-reported pain and electrodermal activity and to create an algorithm that detects pain and provides timely alarms for rising pain levels in patients with life-threatening illnesses suffering from persistent pain. The study is exploratory. Hypothesis: Electrodermal activity can distinguish different pain intensity levels in patients with chronic pain and a life-threatening disease. Methodology: Thirty-seven patients with cancer and/or chronic obstructive pulmonary disease (COPD) will be identified through hospital record screening. These patients will wear a monitoring device for a maximum of one week and report their pain intensity throughout the day. Analysis: Discriminant analysis will be used to differentiate between mild, moderate, and severe pain. This study is exploratory, generating hypotheses for subsequent phases of the project.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-11-05; most recent amendment 2026-03-18.
Status change: Recruiting → Active, Not Recruiting 2026-03-18
Trial Details
NCT Number NCT06677593
Lead Sponsor Copenhagen University Hospital, Hvidovre
Collaborators: Aalborg University Hospital
Conditions Cancer, Chronic Obstructive Pulmonary Disease (COPD, Pain
Enrollment 37 participants
Start Date 2024-11-15
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-19